Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents [note 4] $ 42,477 $ 27,897
Restricted cash [note 4]   251
Short-term investments [note 4] 23,460 19,160
Interest receivable 48 113
Amounts receivable 13 5,676
Prepaid expenses 1,599 2,165
Other current assets   499
Total current assets 67,597 55,761
Restricted cash [note 4] 222  
Property and equipment, net 380 257
Other assets 38 273
Total assets 68,237 56,291
Current liabilities:    
Accounts payable 1,779 72
Accrued liabilities other 811 863
Accrued clinical liabilities 9,968 13,462
Accrued compensation 1,610 1,333
Current portion of long-term obligations [note 6 and 7] 53 236
Lease termination liability [note 6 and note 7] 1,250 3,250
Deferred collaboration revenue [note 3] 11,041  
Warrant liability [note 4 and note 5] 2,836 3,002
Total current liabilities 29,348 22,218
Long-term obligations, less current portion [note 7] 117 14
Total liabilities $ 29,465 $ 22,232
Commitments and contingencies [note 7]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 29,832,907 and 22,630,652 issued at Sept 30, 2015 and December 31, 2014, respectively, and 29,798,914 and 22,621,426 outstanding at Sept 30, 2015 and December 31, 2014, respectively $ 30 $ 22
Additional paid-in capital 211,187 191,373
Accumulated deficit (175,087) (159,958)
Accumulated other comprehensive income 2,642 2,622
Total stockholders' equity 38,772 34,059
Total liabilities and stockholders' equity $ 68,237 $ 56,291